Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycyrrhizin vs Calcium Hydroxide in Root Canal Treatment
NCT06291623Phase 1Completed
- Sponsor
- Mansoura University
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of glycyrrhizin in pulp necrosis and apical periodontitis (AP) (2 arms), sponsored by Mansoura University. Primary endpoint: Minimizing of viable bacteria at 1 week. Started May 2022; status: completed.
02
Drugs
glycyrrhizin
03
Conditions
pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT06291623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06291623.